Who's Driving? Switch of Drivers in Immunotherapy-Treated Progressing Sinonasal Melanoma.

导出 OA

翻译打印收藏纠错

作者： Sandra N,Freiberger ^[1] ; Patrick,Turko ^[2] ; Martin,Hüllner ^[3] ; Reinhard,Dummer ^[2] ; Grégoire B,Morand ^[4] ; Mitchell P,Levesque ^[2] ; David,Holzmann ^[3] ; Niels J,Rupp ^[2]

作者单位： Department of Pathology and Molecular Pathology, University Hospital Zurich, 8091 Zurich, Switzerland. ^[1] Faculty of Medicine, University of Zurich, 8006 Zurich, Switzerland. ^[2] Department of Dermatology, University Hospital Zurich, 8058 Zurich, Switzerland. ^[3] Department of Nuclear Medicine, University Hospital Zurich, 8091 Zurich, Switzerland. ^[4] Department of Otorhinolaryngology, Head and Neck Surgery, University Hospital Zurich, 8091 Zurich, Switzerland. ^[5] Department of Otolaryngology, Head and Neck Surgery, Sir Mortimer B. Davis-Jewish General Hospital, McGill University, Montreal, QC H3T 1E2, Canada. ^[6]

关键词 disease monitoring immunotherapy mucosal melanoma oncogenic driver sinonasal cancer tumor heterogeneity

DOI 10.3390/cancers13112725

PMID 34072863

发布时间 2021-06-15

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交